p-Nrf2/HO-1 Pathway Involved in Methamphetamine-induced Executive Dysfunction through Endoplasmic Reticulum Stress

Tao Wei1,2, Jun-Da Li1, Yu-Jing Wang1

  • 1School of Mental Health, Bengbu Medical College, Bengbu, 233030, Anhui, China.

Insights

Methamphetamine abuse impairs executive function by affecting the p-Nrf2/HO-1 pathway. Activating this pathway with TBHQ can reverse methamphetamine-induced damage and restore cognitive function.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Molecular Biology

Background:

  • Methamphetamine (METH) abuse is a significant public health issue linked to executive dysfunction.
  • The precise molecular mechanisms driving METH-induced cognitive deficits, particularly executive dysfunction, are not fully understood.

Purpose of the Study:

  • To investigate the molecular underpinnings of METH-induced executive dysfunction.
  • To explore the role of oxidative stress, endoplasmic reticulum (ER) stress, and apoptosis in the dorsal striatum following METH exposure.

Main Methods:

  • A Go/NoGo experiment was used to assess executive function in mice exposed to METH.
  • Immunoblot analysis, Malondialdehyde (MDA) levels, glutathione peroxidase (GSH-Px) activity, and TUNEL staining were employed to evaluate molecular changes.
  • The Nrf2 agonist Tert-butylhydroxyquinone (TBHQ) was microinjected into the dorsal striatum to assess its protective effects.

Main Results:

  • METH exposure significantly impaired inhibitory control, a key aspect of executive function.
  • METH treatment led to decreased expression of phosphorylated Nrf2 (p-Nrf2) and heme-oxygenase-1 (HO-1), alongside increased markers of ER stress and apoptosis in the dorsal striatum.
  • TBHQ administration reversed METH-induced deficits in p-Nrf2, HO-1, GSH-Px, ER stress, apoptosis, and executive dysfunction.

Conclusions:

  • The p-Nrf2/HO-1 pathway plays a crucial role in mediating METH-induced executive dysfunction.
  • Targeting the p-Nrf2/HO-1 pathway may offer a therapeutic strategy to mitigate the cognitive impairments associated with METH abuse by reducing ER stress and apoptosis.

Related Concept Videos

The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
4.8K
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.7K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.5K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.7K
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K